# A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults

> **NCT06493461** · PHASE1 · TERMINATED · sponsor: **35Pharma Inc** · enrollment: 5 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension (PAH)

## Interventions

- **BIOLOGICAL:** HS135

## Key facts

- **NCT ID:** NCT06493461
- **Lead sponsor:** 35Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-10-23
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Sponsor's Decision
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06493461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06493461, "A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06493461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*